Patents Assigned to University of Jerusalem
  • Patent number: 10750693
    Abstract: Provided are tomato plants having fruit with red and yellow segments that appear across the fruit from the internal seed area to the most external layer of the epidermis. The present invention discloses that this phenotype, designated Arlecchino, is linked to insertion mutation within the Phytoene synthase 1 (Psy1) gene.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: August 25, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Joseph Hirschberg, Dani Zamir, Yaacov Micha Brog, Itay Zemach, Orly Dery
  • Patent number: 10750701
    Abstract: Provided relates to a crop Lisianthus (Eustoma grandiflorum) plants that do not require cold treatment (vernalization) for the inductions of bolting and flowering, and to means and methods for producing same.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: August 25, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Avichai Amrad, Kfir Bandel, Tzili Pleban, Dani Zamir
  • Patent number: 10731156
    Abstract: Provided are oligonucleotides capable of binding to and modulating the splicing of the pre-mRNA of the CFTR gene, compositions including said oligonucleotides, kits including the compositions, and uses thereof. In particular, the subject matter provides compositions of oligonucleotides useful in methods for suppressing exon skipping optionally in combination with additional CFTR therapeutics.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: August 4, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Batsheva Kerem, Michal Tur Sinai, Loren Price, Stephen Donald Wilton, Sue Fletcher
  • Publication number: 20200239398
    Abstract: Methylene-cycloalkylacetate compounds and derivatives thereof and their use in methods for treatment of neurotropic conditions.
    Type: Application
    Filed: December 15, 2019
    Publication date: July 30, 2020
    Applicant: Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
    Inventors: Dmitry TSVELIKHOVSKY, Philip LAZAROVICI, Dikla HAHAM, David LANKRI
  • Patent number: 10722599
    Abstract: Provided are modified lipid compounds and their use in the formation of lipid assemblies. Also provided are lipid assemblies including (a) an amphoteric lipid including in covalent association with (i) one or more acyl chains; (ii) one or more weak base moiety; (iii) one or more weak acid moiety; the lipid assembly also including (b) one or more additional lipids, at least one of which being a zwitterionic lipid. In some embodiments, the amphoteric lipid is a compound including (a) a tri-functional moiety; (b) two non-phosphate lipid chains associated with two of the functional moieties of said tri-functional moiety; (c) optionally a spacer moiety associated with the third of the functional moieties of said tri-functional moiety; and (d) a polyalkylamine optionally including a short peptide with one to several carboxylic acid residues. Further provided are the uses of the lipid assembly, inter alia, for transfection or cancer treatment.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: July 28, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Yechezkel Barenholz, Rivka Cohen, Kirill Makedonski, Eylon Yavin, Andreas Ingemann Jensen, Keren Turjeman
  • Patent number: 10716825
    Abstract: Disclosed are methods for treating, preventing and alleviating obesity, fatty liver syndrome, diabetes, one or more metabolic syndrome conditions or complications and/or cancer comprising administering an effective amount of ostreolysin, its functionally related variant, or an extract or mushroom extract comprising the same to subjects in need thereof.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: July 21, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Betty Schwartz, Einav Yehuda-Shnaidman, Lili Nimri
  • Publication number: 20200225579
    Abstract: Provided is a novel class of solid water-dispersible powders, including a plurality of water-insoluble photoinitiators in nanoparticle forms for use in water-based ink formulations.
    Type: Application
    Filed: March 20, 2020
    Publication date: July 16, 2020
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Shlomo MAGDASSI, Liraz LARUSH, Ido COOPERSTEIN, Amol Ashok PAWAR
  • Patent number: 10694968
    Abstract: Systems and method for classifying EEG signals of a human subject generated responsive to a series of images containing target images and non-target images. The EEG signals are in a spatio-temporal representation. The time points are classified independently, using a linear discriminant classifier, to compute spatio-temporal discriminating weights that are used to amplify the spatio-temporal representation, to create a spatially-weighted representation. Principal Component Analysis is used on a temporal domain for dimensionality reduction, separately for each spatial channel of the signals, to create a projection, which is applied to the spatially-weighted representation onto a first plurality of principal components, to create a temporally approximated spatially weighted representation.
    Type: Grant
    Filed: April 13, 2014
    Date of Patent: June 30, 2020
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University
    Inventors: Leon Y. Deouell, Amir B. Geva, Galit Fuhrmann Alpert, Ran El Manor, Shani Shalgi
  • Patent number: 10695462
    Abstract: The invention disclosed herein generally provides implantable medical devices and implants that may be removed on-demand from a subject's body at any time after their implanting in the body, without necessitating invasive procedures.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: June 30, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Oded Shoseyov, Danny Porath, Ofra Benny, Yaron Bar-Lavie, Amos Ofer
  • Publication number: 20200181234
    Abstract: Isolated polypeptides of CD44 are provided. Accordingly, there is provided an isolated polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-3. Also provided is an isolated end-capping modified polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1-3, wherein the modified polypeptide comprises an anti-inflammatory activity. Also provided are compositions of matter, fusion proteins and pharmaceutical compositions and their use in the treatment of inflammatory disease.
    Type: Application
    Filed: February 18, 2020
    Publication date: June 11, 2020
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: David NAOR, Lora ESHKAR-SEBBAN, Keren-Or AMAR, Shmuel COHEN
  • Patent number: 10669390
    Abstract: Provided is a unique class of foam materials characterized by regions of material unidirectionality. The foam materials are configured for a great variety of end-use applications as core materials or as materials in construction of multilayered structures. The novel and ingenious process for making the composite materials of the invention, permits modifying the foam materials to suite any specific end use.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: June 2, 2020
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Melodea Ltd.
    Inventors: Shaul Lapidot, Sigal Roth Shalev, Rikard Slattegard, Oded Shoseyov, Clarite Azerraf, Ido Braslavsky, Victor Yashunsky
  • Patent number: 10662225
    Abstract: Provided are backbone cyclized peptides that interfere with signaling of the intracellular adaptor protein MyD88. Pharmaceutical compositions including these backbone cyclized peptides as well as their use in treatment of multiple sclerosis (MS) and other diseases associated with MyD88 signaling are also disclosed.
    Type: Grant
    Filed: June 4, 2017
    Date of Patent: May 26, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Gabriel Nussbaum, Amnon Hoffman, Chaim Gilon
  • Publication number: 20200138977
    Abstract: Provided herein are pre-lyophilized compositions containing a nucleic acid, a cationic polymer, and a carbohydrate. Also provided are lyophilized compositions of matter and reconstituted compositions as well as methods of making using the same for treating tumors in patients.
    Type: Application
    Filed: January 2, 2020
    Publication date: May 7, 2020
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Abraham HOCHBERG, Jennifer GALLULA
  • Publication number: 20200121581
    Abstract: Provided are methods, compositions and kits employing cellulose nanocrystals for hair-straightening treatment. Also provided are methods, compositions and kits employing a resilin, for hair-straightening treatment and/or for maintenance of straightened hair following a hair-straightening treatment.
    Type: Application
    Filed: April 4, 2018
    Publication date: April 23, 2020
    Applicants: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Smart Resilin Ltd.
    Inventors: Oded SHOSEYOV, Roni SHALEV, Sigal BARUCH-SHARON, Tal BEN SHALOM, Liron NUTTMAN-NESIAL
  • Patent number: 10624851
    Abstract: The present invention provides liposomes comprising a lipid bilayer and a polymer-conjugated lipid, wherein said polymer-conjugated lipid is incorporated into said lipid bilayer. The present invention also provides methods of producing the liposomes as well as a method of delivering a nucleic acid to a subject comprising the step of administering said nucleic acid encapsulated in a mixed liposome, a method for performing diagnostic imaging in a subject, comprising the step of administering a diagnostic agent encapsulated in a mixed liposome, and methods for treating, inhibiting, or suppressing a pathological condition in a subject comprising administering to said subject a mixed liposome.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: April 21, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd
    Inventor: Saul Yedgar
  • Publication number: 20200108037
    Abstract: The present invention is directed to a fatty acid amide of an amino acid, including a stereoisomer and a salt thereof for use in the treatment of a patient suffering from any type of addiction disorder, substance abuse disorder, including any condition and symptom associated therewith and including withdrawal syndrome and relapse addiction during and after a rehabilitation treatment of said patient.
    Type: Application
    Filed: May 22, 2018
    Publication date: April 9, 2020
    Applicants: Yissum Research Development Company of The Hebrew University of Jerusalem Ltd., VIRGINIA COMMONWEALTH UNIVERSITY, UNIVERSITY OF GUELPH
    Inventors: Raphael MECHOULAM, Vincenzo DI MARZO, Fabiana PISCITELLI, Aron H. LICHTMAN, Imad M. DAMAJ, Linda PARKER, Rami YAKA
  • Patent number: 10611819
    Abstract: Isolated polypeptides of CD44 are provided. Accordingly, there is provided an isolated polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-3. Also provided is an isolated end-capping modified polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1-3, wherein the modified polypeptide comprises an anti-inflammatory activity. Also provided are compositions of matter, fusion proteins and pharmaceutical compositions and their use in the treatment of inflammatory disease.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: April 7, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: David Naor, Lora Eshkar-Sebban, Keren-Or Amar, Shmuel Cohen
  • Publication number: 20200087148
    Abstract: Provided is a composite of a CNT assembly including a plurality of carbon nanotubes (CNTs) and at least one metalcone material, the composite being tunable, by a vapor phase chemical modification, to adopt one or more collective properties selected from mechanical, chemical, physical or electrical properties.
    Type: Application
    Filed: February 21, 2018
    Publication date: March 19, 2020
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventor: Roie YERUSHALMI
  • Publication number: 20200079738
    Abstract: The present invention provides processes for the preparation of diverse heterocyclic scaffolds from alpha-enaminone building bloc of formula (I).
    Type: Application
    Filed: March 21, 2018
    Publication date: March 12, 2020
    Applicant: Yissum Research Development Company, of The Hebrew University of Jerusalem Ltd.
    Inventor: Dmitry TSVELIKHOVSKY
  • Publication number: 20200075034
    Abstract: A method and system for enhancing a speech signal is provided herein. The method may include the following steps: obtaining an original video, wherein the original video includes a sequence of original input images showing a face of at least one human speaker, and an original soundtrack synchronized with said sequence of images; and processing, using a computer processor, the original video, to yield an enhanced speech signal of said at least one human speaker, by detecting sounds that are acoustically unrelated to the speech of the at least one human speaker, based on visual data derived from the sequence of original input images.
    Type: Application
    Filed: November 11, 2019
    Publication date: March 5, 2020
    Applicant: Yissum Research Development Company of The Hebrew University of Jerusalem LTD.
    Inventors: Shmuel PELEG, Asaph SHAMIR, Tavi HALPERIN, Aviv GABBAY, Ariel EPHRAT